“…Endocrine disrupting potential of cimetidine has also been suggested in several in vitro, and in vivo experimental and clinical studies. Cimetidine competes with androgen for binding to androgen receptors in rat ventral prostate cells and fibroblasts (Sultan et al, 1980;Winters et al, 1980). Cimetidine exposure in rats resulted in decreased serum testosterone levels as well as reduced weight of androgen-dependent tissues, e.g., testes and prostate (Baba et al, 1981;Peden et al, 1981;Anand and Van Thiel, 1982).…”